fda on compounded semaglutide issues warning about some versions of for diabetes, weight loss 🚨 FDA Removes Compounded Semaglutide

#GLP-1 receptor agonist exposure with discontinuation before or during early #pregnancy was associated with greater gestational weight gain and increased risk of preterm delivery, gestational #diabetes, and hypertensive disorders

Following a 2-month washout period, the mean MDS-UPDRS motor scores in the off-medication state were 2.9 points higher in the placebo group, underscoring the potential benefits of lixisenatide in early PD [100]

All of these mechanisms can cause noticeable weight loss without feeling like you're starving

But Early Success Doesnt Mean It Works in Humans Even though the results are impressive, this research is still early